The Clinical Research and Development team at Eidos Therapeutics is dedicated to designing, implementing, and overseeing clinical trials aimed at evaluating the safety and efficacy of AG10 for transthyretin amyloidosis. This team, composed of experienced professionals in clinical operations and regulatory affairs, collaborates closely to ensure trials meet regulatory standards and are conducted efficiently, ultimately working to bring innovative therapies to patients in need.
View all